UCLA's Jonsson Comprehensive Cancer Center (JCCC) has over 240 researchers and clinicians engaged in disease research, prevention, detection, control, treatment and education.
One of the nation's largest comprehensive cancer centers, JCCC is dedicated to promoting research and translating basic science into leading-edge clinical studies. JCCC has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments.
JCCC's strength is in the collaboration between people working in all areas of cancer. Cancer prevention experts work with cancer survivor experts to study how to keep cancer from beginning or returning. They work in turn with scientists who study the causes and behaviors of the disease in all its living contexts. Researchers working in labs speak continually with the doctors who treat patients so that they can learn from each other. Many of our scientists are doctors and educators as well. Our top-notch physicians and scientists, both generalists and specialists, form one of the largest communities of cancer experts in the world.
Successful targeted therapies such as Herceptin, Gleevec, and Sprycel were developed based on basic science performed in JCCC laboratories and later clinical trials (new treatment studies) with JCCC patients. Learn more about us and our work as a comprehensive cancer center and about cancer research at JCCC.